ARS Pharmaceuticals (SPRY) Net Income

Annual Net Income

-$54.37 M
-$19.68 M-56.75%

December 31, 2023


Summary


Performance

SPRY Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYprofitabilitymetrics:

Quarterly Net Income

-$19.13 M
-$6.61 M-52.83%

September 30, 2024


Summary


Performance

SPRY Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYprofitabilitymetrics:

TTM Net Income

-$49.10 M
-$4.26 M-9.50%

September 30, 2024


Summary


Performance

SPRY TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRYprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SPRY Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-56.8%-52.8%-9.5%
3 y3 years-5004.7%-52.8%-9.5%
5 y5 years-5004.7%-52.8%-9.5%

SPRY Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-168.6%at low-197.9%at low-577.3%+20.3%
5 y5-year-5004.7%at low-197.9%at low-577.3%+20.3%
alltimeall time-5004.7%at low-197.9%at low-577.3%+20.3%

ARS Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$19.13 M(+52.8%)
-$49.10 M(+9.5%)
Jun 2024
-
-$12.52 M(+21.6%)
-$44.84 M(-9.8%)
Mar 2024
-
-$10.29 M(+43.6%)
-$49.70 M(-8.6%)
Dec 2023
-$54.37 M
-$7.17 M(-51.8%)
-$54.37 M(-11.8%)
Sep 2023
-
-$14.87 M(-14.4%)
-$61.63 M(+15.5%)
Jun 2023
-
-$17.37 M(+16.1%)
-$53.34 M(+25.8%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$14.96 M(+3.7%)
-$42.39 M(+22.2%)
Dec 2022
-$34.68 M(+71.3%)
-$14.43 M(+119.2%)
-$34.68 M(+71.2%)
Sep 2022
-
-$6.58 M(+2.5%)
-$20.25 M(+48.2%)
Jun 2022
-
-$6.42 M(-11.4%)
-$13.67 M(+88.6%)
Mar 2022
-
-$7.25 M
-$7.25 M
Dec 2021
-$20.24 M(+1800.8%)
-
-
Dec 2020
-$1.06 M
-
-

FAQ

  • What is ARS Pharmaceuticals annual net profit?
  • What is the all time high annual net income for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual net income year-on-year change?
  • What is ARS Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly net income year-on-year change?
  • What is ARS Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals TTM net income year-on-year change?

What is ARS Pharmaceuticals annual net profit?

The current annual net income of SPRY is -$54.37 M

What is the all time high annual net income for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual net profit is -$1.06 M

What is ARS Pharmaceuticals annual net income year-on-year change?

Over the past year, SPRY annual net profit has changed by -$19.68 M (-56.75%)

What is ARS Pharmaceuticals quarterly net profit?

The current quarterly net income of SPRY is -$19.13 M

What is the all time high quarterly net income for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly net profit is -$6.42 M

What is ARS Pharmaceuticals quarterly net income year-on-year change?

Over the past year, SPRY quarterly net profit has changed by -$6.61 M (-52.83%)

What is ARS Pharmaceuticals TTM net profit?

The current TTM net income of SPRY is -$49.10 M

What is the all time high TTM net income for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high TTM net profit is -$7.25 M

What is ARS Pharmaceuticals TTM net income year-on-year change?

Over the past year, SPRY TTM net profit has changed by -$4.26 M (-9.50%)